GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (FRA:FEQ1) » Definitions » Long-Term Capital Lease Obligation

Laboratorio Reig Jofre (FRA:FEQ1) Long-Term Capital Lease Obligation : €9.9 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorio Reig Jofre Long-Term Capital Lease Obligation?

Laboratorio Reig Jofre's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €9.9 Mil.

Laboratorio Reig Jofre's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (€10.5 Mil) to Sep. 2023 (€9.6 Mil) but then increased from Sep. 2023 (€9.6 Mil) to Dec. 2023 (€9.9 Mil).

Laboratorio Reig Jofre's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€14.4 Mil) to Dec. 2022 (€12.0 Mil) and declined from Dec. 2022 (€12.0 Mil) to Dec. 2023 (€9.9 Mil).


Laboratorio Reig Jofre Long-Term Capital Lease Obligation Historical Data

The historical data trend for Laboratorio Reig Jofre's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Long-Term Capital Lease Obligation Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.60 15.86 14.39 11.97 9.87

Laboratorio Reig Jofre Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.97 10.49 9.55 9.87 -

Laboratorio Reig Jofre  (FRA:FEQ1) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Laboratorio Reig Jofre Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (FRA:FEQ1) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.

Laboratorio Reig Jofre (FRA:FEQ1) Headlines

No Headlines